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Background: Convenience is a major reason for using killed preparations of bacteria to investigate host-pathogen
interactions, however, host responses to such preparations can result in different outcomes when compared to live
bacterial stimulation. We investigated whether cryopreservation of Streptococcus pneumoniae and nontypeable
Haemophilus influenzae (NTHi) permitted investigation of host responses to infection without the complications of
working with freshly prepared live bacteria on the day of experimental challenge.
Findings: S. pneumoniae and NTHi retained >90% viability following cryopreservation in fetal calf serum for at least
8 weeks. Host responses to live, cryopreserved (1 week and 4 weeks), heat-killed or ethanol-killed S. pneumoniae
and NTHi were assessed by measuring cytokine release from stimulated peripheral blood mononuclear cells
(PBMCs). We found that cryopreserved bacteria, in contrast to heat-killed and ethanol-killed preparations, resulted in
comparable levels of inflammatory cytokine release from PBMCs when compared with fresh live bacterial cultures.
Conclusion: Cryopreservation of S. pneumoniae and NTHi does not alter the immunostimulatory properties of these
species thereby enabling reproducible and biologically relevant analysis of host responses to infection. This method
also facilitates the analysis of multiple strains on the same day and allows predetermination of culture purity and
challenge dose.
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PBMCsBackground
Many research laboratories, by necessity, use heat-killed,
ethanol-killed, UV-irradiated or paraformaldehyde-fixed
bacterial preparations to investigate host-bacterial interac-
tions. However, stimulation of host immune cells with
such inactivated preparations can result in very different
outcomes when compared with live bacterial stimulation
[1-3]. We have shown that in comparison with live
Staphylococcus epidermidis, heat-killed and ethanol-killed
S. epidermidis preparations have a reduced capacity to* Correspondence: lea-ann.kirkham@uwa.edu.au
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reproduction in any medium, provided the oractivate key innate immune pathways, especially those
associated with cytosolic/endosomal bacterial recognition
[3]. In addition, Mogensen and colleagues have demon-
strated that live but not heat-killed preparations of
Streptococcus pneumoniae and Neisseria meningitidis
stimulated the host inflammatory response through
Toll-like receptor 9 [2].
Convenience is a major reason for using killed prepa-
rations of bacteria to investigate host-pathogen interac-
tions. Working with live bacteria usually requires growth
to mid-log phase on the day of the stimulation expe-
riment to ensure consistent and reproducible host res-
ponses. The time required for mid-log growth on the
day of experimentation varies for different bacteria and
can take up to 8 hours, which restricts the number ofl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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available for experimental challenge. In addition, culture
contamination is usually only apparent on the day after
experimental challenge of the host cells/animal models
by checking purity of the culture on an agar plate incu-
bated overnight. An alternative to broth cultures is to
harvest bacteria from an overnight agar plate and resus-
pend in media to the desired optical density, which
roughly correlates with bacteria/ml [4]. However, this
means that the majority of bacteria are either in statio-
nary phase or indeed dead when used to assess the host
response, and results can vary accordingly. We herein
describe a simple cryopreservation method using fetal
calf serum (FCS) to store mid-log phase S. pneumoniae
and NTHi for at least 8 weeks without a significant re-
duction in viability. We have used a PBMC stimulation
assay to demonstrate that preparations of S. pneumoniae
and NTHi frozen for up to 4 weeks retain the immunos-
timulatory properties of freshly prepared live bacterial
preparations, whereas heat-killed and ethanol-killed pre-
parations do not.
Findings
There was a dip in viability when S. pneumoniae and
NTHi were initially frozen, however, both species re-
tained over 90% viability following 8 weeks cryopreser-
vation (92.6 and 97.0% respectively when compared with
1 day of cryopreservation), Figure 1. Viability at 16 weeks
cryopreservation was also measured and found to still
be >90% for both species (data not shown).
With assurance that S. pneumoniae and NTHi re-
mained viable following cryopreservation, we then chal-
lenged PBMCs from 5 adult donors with preparations of
bacteria that were either frozen for 1 or 4 weeks and
compared this with PBMCs challenged with heat-killed,Figure 1 Viability of S. pneumoniae and NTHi over 8 weeks of
storage at −80°C. The count on day 0 is a total bacteria count
using a chamber (bacteria/ml), thereafter viable counts were
conducted with the frozen bacteria to give LOG cfu/ml at 1 day,
1 week, 4 weeks and 8 weeks post-freezing.ethanol-killed or live preparations prepared on the day
of challenge. PBMC release of 5 inflammatory cytokines
was measured as an indication of the immunostimula-
tory properties of the bacterial preparations. We found
that there was no difference in the immunostimulatory
properties of frozen S. pneumoniae and NTHi compared
with live bacteria regardless of whether the bacteria were
stored at −80°C for 1 or 4 weeks (Figure 2). In contrast,
stimulation of PBMCs with ethanol-killed preparations
resulted in production of significantly lower levels of
IL-6, IL-10, TNFα and IL-1β for S. pneumoniae, and
IFNγ and IL-1β for NTHi, when compared with live or
frozen preparations (Figure 2, P < 0.05). Heat-killing
retained slightly more immunostimulatory properties
than ethanol-killing but there was still reduced immuno-
stimulation in comparison with live or frozen bacteria.
No IFNγ was released from PBMCs stimulated with
either heat or ethanol-killed S. pneumoniae preparations,
whereas an average of 200 pg/ml IFNγ was released
upon stimulation with live or frozen S. pneumoniae. For
NTHi, the IL-6, IL-10 and TNFα response was not
dependent upon the bacterial treatment with high levels
of cytokine production from live, frozen and killed
preparations.
Conclusions
We have described a simple and practical method that
enables investigation of live host-pathogen interactions
without the restrictions that are normally associated
with working with live bacteria such as experimental
time, contamination, intra-assay variation and scalability.
Serum is a known microbial cryoprotectant [5] and al-
though a similar storage method has been used with
S. pneumoniae for challenge of mice [6] we have pro-
vided a detailed methodology and clearly demonstrated
that cryopreservation of S. pneumoniae and NTHi with
FCS preserves the immunostimulatory properties of
these species. We have also confirmed that cryopreser-
vation is superior to other methods for standardisation
and storage of bacteria that involve inactivation.
Different methods of killing bacteria can alter the im-
munostimulatory profile of the pathogen either by expo-
sing or destroying PAMPs [1-3]. This was evident in our
study where heat and ethanol treatment of S. pneumoniae
but not NTHi attenuated the IL-6 and IL-10 response
from PBMCs. This is most likely to be due to the killing
treatments destroying key pneumococcal virulence factors
such as pneumolysin [1] but not lipooligosaccharide from
NTHi, which is heat-stable. This highlights how using
killed preparations of bacteria can result in an under or
over-stated host immune response to the remaining
immunostimulatory components and may result in mis-
leading conclusions about host–pathogen interactions. In
summary, we have developed a straightforward and
Figure 2 Cytokine release (pg/ml) from adult PBMCs following stimulation with live, killed or cryopreserved bacteria. Adult PBMCs were
stimulated for 24 h with 1 × 107 bacteria/ml of live, frozen 1 week (fzn 1wk), frozen 4 weeks (fzn 4wk), heat-killed (HK) or ethanol-killed (EK)
S. pneumoniae and nontypeable H. influenzae (NTHi), lipopolysaccharide (LPS), or Staphylococcal enterotoxin B (SEB). The horizontal bars depict
the median cytokine level for each treatment group (n = 5), * = P < 0.05 when compared with live or frozen bacteria.
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that cryopreserved bacteria remain viable for at least
8 weeks and maintain their stimulatory capacities for at
least 4 weeks (later time points were not tested). This
technique facilitates the analysis of multiple bacterial
species on the same day, allows predetermination of cul-
ture purity and viability, and most importantly enables
accurate investigation of the host response to live bac-
terial infection.
Methods
Bacterial strains, culture and cryopreservation
All reagents were from Sigma Aldrich, New South Wales,
Australia unless otherwise stated. Glycerol stocks of
S. pneumoniae D39 (ATCC#7466) and NTHi 289 [7] were
streaked out onto blood agar or chocolate agar plates
respectively for single colonies and incubated at 37°C.
S. pneumoniae was incubated anaerobically using the BD
GasPak™ EZ Anaerobic Pouch System [BD Diagnostics,Australia]. Following overnight incubation, three colonies
were selected from each agar plate and used to inoculate
culture media. S. pneumoniae was grown statically in brain
heart infusion (BHI) broth at 37°C and NTHi was grown
with shaking in BHI supplemented with 44 mL/L glycerol,
30 mg/L hemin and 10 mg/L nicotinamide adenine di-
nucleotide (NAD). Both strains were grown to mid-log
phase (OD600nm 0.55 – 0.65), counted at 100 × mag-
nification using a Helber bacteria counting chamber
[ProSciTech, Queensland, Australia] and then either
subjected to the different treatments (heat, ethanol or
freezing) or used fresh on the day of preparation. All cul-
tures were streaked onto agar plates and incubated at 37°C
overnight to check purity. For cultures that were to be fro-
zen, heat-inactivated FCS [SAFC Biosciences, New South
Wales, Australia] was added to the mid-log phase culture
to give a final concentration of 20% FCS and 1 mL aliquots
were stored in cryovials at -80°C. FCS was the only cryo-
protectant used for storage of these bacterial stocks.
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Vials of frozen bacterial stocks were thawed at 37°C for
2 min in a water bath, 900 μL was transferred to a fresh
tube and centrifuged in a benchtop centrifuge at maxi-
mum speed for 3 min. The supernatant was discarded
and pellet resuspended in 900 μL of sterile phosphate
buffered saline (PBS) pH 7.4 [Gibco, New South Wales,
Australia]. Ten-fold dilutions of each bacteria ranging
from 10-1 to 10-6 were prepared with PBS in a 96-well
polystyrene round bottom plate. Agar plates were di-
vided into 6 sectors, using 2 plates per strain, and three
20 μL aliquots of the dilutions were spotted onto each
sector. Plates were allowed to dry then incubated over-
night at 37°C. The following day, the number of colony
forming units (cfu) per 20 μl spot were counted in the
sector with approximately 20 – 80 cfu, averaged and
multiplied by the dilution factor to give cfu/mL. Viable
counts of cryopreserved bacteria were conducted at
1 day, 1 week, 4 weeks, 8 weeks and 16 weeks post-
freezing.
Heat-killing and ethanol-killing of bacteria
Mid-log phase cultures of S. pneumoniae and NTHi
were centrifuged at 3200 g for 10 min, washed in PBS,
and viable counts were conducted as described above.
For heat-killing, the bacteria in PBS were incubated in a
water bath at 60°C for 1 h. For ethanol-killing, the bac-
teria were resuspended in 70% ethanol and incubated at
4°C for 1 h with rotation. After killing, bacteria were
washed in PBS, aliquoted and stored at 4°C. Chamber
counts were conducted on the killed preparations to de-
termine bacteria/mL and viable counts were conducted
to confirm successful killing.
PBMC collection, processing and stimulation with live,
frozen, heat-killed and ethanol-killed preparations of
bacteria
Whole blood was collected from five healthy adult donors
by peripheral venepuncture and mixed 1:1 with hepa-
rinised (2%) RPMI 1640 media supplemented with 1%
sodium pyruvate, 1% glutamax, 10 mM HEPES buffer
[All Gibco]. The PBMCs were processed and stored as
previously described [3]. On the day of stimulation,
PBMCs were thawed at 37°C for 2 min in a water bath,
added to 2% FCS RPMI 1640 and centrifuged at 500 g for
10 min at room temperature. The supernatant was
discarded and cells resuspended in media and counted.
The PBMCs were seeded in triplicate for each stimuli at
2.5 × 105 cells per well in 96-well polypropylene round-
bottom plates and incubated for 24 h at 37°C in a humi-
dified 5% CO2 environment. PBMCs were stimulated with
either live, heat-killed, ethanol-killed, frozen for 1 week or
frozen for 4 week preparations of S. pneumoniae D39 and
NTHi 289 at a multiplicity of infection of 10:1 bacteria tocells. Live and frozen bacteria viable counts were deter-
mined as described above and total bacterial chamber
counts were conducted for the heat- and ethanol-killed
preparations. Cells in control wells were stimulated with
either PBS (cells only), 1 ng/mL lipopolysaccharide
(LPS, from E. coli R515) [Alexis Biochemicals, Sapphire
Biosciences, NSW, Australia] or 1 μg/mL staphylococcal
enterotoxin B (SEB, from S. aureus). At 24 h post-
stimulation, plates were centrifuged for 5 min at 200 g
and supernatants were harvested, triplicate wells com-
bined and then stored in aliquots at -80°C for subse-
quent measurement of inflammatory mediators.
Measurement of inflammatory mediators
IL-6, IL-10, IFNγ and TNFα levels (pg/mL) were mea-
sured in cell culture supernatants using a previously des-
cribed multiplex cytokine bead assay [8]. IL-1β levels in
cell supernatants were measured using an ELISA kit
[Bender MedSystems, California, USA] and following
the manufacturer’s instructions, except wells were coated
with an alkaline coating buffer (40 mM NaCo3; 70 mM
NaHCO3) instead of PBS.
Statistical analyses
PBMC cytokine release following different treatments
was compared using a Kruskal-Wallis test with Dunn’s
post-test analysis using GraphPad Prism [GraphPad Soft-
ware Inc, California, USA], where P < 0.05 was con-
sidered statistically significant. For IL-1β one outlier was
excluded from analysis due to an out of range maximum
value.
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